Please login to the form below

Not currently logged in
Email:
Password:

Three new members at ABPI

ALK- Abello, Shionogi and Randox join UK trade body

The trade body for the UK's pharma industry has added three new companies to its list of members.

The Association of the British Pharmaceutical Indsitry (ABPI) said that ALK- Abell and Shionogi have joined its ranks as full members, while Randox has become a research affiliate.

ALK- Abello is a specialist biopharma company, which is focused on the development of treatments for people with allergies.

This includes Pharmalgen, which was recommended in Europe last year as a treatment option for bee and wasp allergy.

Shionogi is a Japan-based pharma firm that is perhaps best known for discovering the blockbuster statin Crestor (rosuvostatin). The company was recently featured in PMLiVE's emerging companies series.

The final new member Randox is a diagnostic solutions company that works with works with pharma and research organisations in the development of companion diagnostics.

“I'm delighted to welcome three new research led companies to the ABPI,” said the body's CEO Stephen Whitehead.

“The industry is experiencing tremendous change and it is an important time for our members while we strive to improve levels of medicines uptake in the UK and as we engage in pricing negotiations with the Department of Health.”

5th February 2013

From: Research, Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....
Personas: a top tool for personalising pharma marketing campaigns
Healthcare customers are calling for greater personalisation in care from providers. Here, we explain why personas are the top tool for ensuring your brand meets this need efficiently and effectively....

Infographics